RESUMO
Carcinoma cells initiate the metastatic cascade by inserting invasive pseudopodia through breaches in the basement membrane (BM), a specialized barrier of cross-linked, extracellular matrix macromolecules that underlies epithelial cells and ensheaths blood vessels. While BM invasion is the sine qua non of the malignant phenotype, the molecular programs that underlie this process remain undefined. To identify genes that direct BM remodeling and transmigration, we coupled high-resolution electron microscopy with an ex vivo model of invasion that phenocopies the major steps observed during the transition of carcinoma in situ to frank malignancy. Herein, a triad of membrane-anchored proteases, termed membrane type-1, type-2, and type-3 metalloproteinases, are identified as the triggering agents that independently confer cancer cells with the ability to proteolytically efface the BM scaffolding, initiate the assembly of invasive pseudopodia, and propagate transmigration. These studies characterize the first series of gene products capable of orchestrating the entire BM remodeling program that distinguishes the carcinomatous phenotype.
Assuntos
Membrana Basal/fisiologia , Metaloproteinases da Matriz Associadas à Membrana/metabolismo , Animais , Membrana Basal/enzimologia , Membrana Basal/ultraestrutura , Células COS , Linhagem Celular , Linhagem Celular Tumoral , Movimento Celular/fisiologia , Chlorocebus aethiops , Colágeno Tipo IV/metabolismo , Matriz Extracelular/metabolismo , Matriz Extracelular/ultraestrutura , Humanos , Metaloproteinase 14 da Matriz/genética , Metaloproteinase 14 da Matriz/metabolismo , Metaloproteinase 15 da Matriz/genética , Metaloproteinase 15 da Matriz/metabolismo , Metaloproteinase 16 da Matriz/genética , Metaloproteinase 16 da Matriz/metabolismo , Metaloproteinases da Matriz Associadas à Membrana/genética , Camundongos , Microscopia Eletrônica de Varredura , Microscopia Eletrônica de Transmissão , Mutação/genética , Invasividade Neoplásica , Neoplasias/metabolismo , Neoplasias/patologia , Neoplasias/fisiopatologia , RNA Interferente Pequeno/genética , Ratos , Inibidores Teciduais de Metaloproteinases/metabolismoRESUMO
White adipose tissue (WAT) serves as the primary energy depot in the body by storing fat. During development, fat cell precursors (i.e., preadipocytes) undergo a hypertrophic response as they mature into lipid-laden adipocytes. However, the mechanisms that regulate adipocyte size and mass remain undefined. Herein, we demonstrate that the membrane-anchored metalloproteinase, MT1-MMP, coordinates adipocyte differentiation in vivo. In the absence of the protease, WAT development is aborted, leaving tissues populated by mini-adipocytes which render null mice lipodystrophic. While MT1-MMP preadipocytes display a cell autonomous defect in vivo, null progenitors retain the ability to differentiate into functional adipocytes during 2-dimensional (2-D) culture. By contrast, within the context of the 3-dimensional (3-D) ECM, normal adipocyte maturation requires a burst in MT1-MMP-mediated proteolysis that modulates pericellular collagen rigidity in a fashion that controls adipogenesis. Hence, MT1-MMP acts as a 3-D-specific adipogenic factor that directs the dynamic adipocyte-ECM interactions critical to WAT development.
Assuntos
Adipócitos/enzimologia , Tecido Adiposo/enzimologia , Tecido Adiposo/crescimento & desenvolvimento , Matriz Extracelular/enzimologia , Metaloproteinases da Matriz/genética , Células-Tronco/enzimologia , Adipócitos/citologia , Adipogenia/fisiologia , Tecido Adiposo/citologia , Animais , Animais Recém-Nascidos , Diferenciação Celular/genética , Crescimento Celular , Colágeno/metabolismo , Colagenases/metabolismo , Matriz Extracelular/genética , Hipertrofia/enzimologia , Metaloproteinase 14 da Matriz , Metaloproteinases da Matriz Associadas à Membrana , Camundongos , Camundongos Knockout , Células-Tronco/citologiaRESUMO
During pathologic vessel remodeling, vascular smooth muscle cells (VSMCs) embedded within the collagen-rich matrix of the artery wall mobilize uncharacterized proteolytic systems to infiltrate the subendothelial space and generate neointimal lesions. Although the VSMC-derived serine proteinases, plasminogen activator and plasminogen, the cysteine proteinases, cathepsins L, S, and K, and the matrix metalloproteinases MMP-2 and MMP-9 have each been linked to pathologic matrix-remodeling states in vitro and in vivo, the role that these or other proteinases play in allowing VSMCs to negotiate the three-dimensional (3-D) cross-linked extracellular matrix of the arterial wall remains undefined. Herein, we demonstrate that VSMCs proteolytically remodel and invade collagenous barriers independently of plasmin, cathepsins L, S, or K, MMP-2, or MMP-9. Instead, we identify the membrane-anchored matrix metalloproteinase, MT1-MMP, as the key pericellular collagenolysin that controls the ability of VSMCs to degrade and infiltrate 3-D barriers of interstitial collagen, including the arterial wall. Furthermore, genetic deletion of the proteinase affords mice with a protected status against neointimal hyperplasia and lumen narrowing in vivo. These studies suggest that therapeutic interventions designed to target MT1-MMP could prove beneficial in a range of human vascular disease states associated with the destructive remodeling of the vessel wall extracellular matrix.
Assuntos
Artérias/metabolismo , Movimento Celular/fisiologia , Colágeno/metabolismo , Matriz Extracelular/metabolismo , Metaloproteinases da Matriz/metabolismo , Miócitos de Músculo Liso/metabolismo , Doenças Vasculares/metabolismo , Animais , Apoptose/fisiologia , Artérias/ultraestrutura , Clonagem Molecular , Imunofluorescência , Técnicas de Transferência de Genes , Marcação In Situ das Extremidades Cortadas , Masculino , Metaloproteinase 14 da Matriz , Metaloproteinases da Matriz/genética , Metaloproteinases da Matriz Associadas à Membrana , Camundongos , Camundongos Mutantes , Microscopia Eletrônica , Miócitos de Músculo Liso/ultraestrutura , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Membrane type 1 matrix metalloproteinase (MT1-MMP) is frequently expressed by cancer cells and is believed to play an important role in cancer cell invasion and metastasis. However, little is known about the role of MT1-MMP in mediating invasiveness of cervical cancer cells. In this study, we examined MT1-MMP expression in 58 primary human cervical tissue specimens, including normal cervix, low-grade squamous intraepithelial lesions (LSIL), high-grade SILs (HSIL), and invasive carcinomas. We also evaluated MT1-MMP, MMP-2, and tissue inhibitor of metalloproteinase-2 expression in several cervical cancer-derived cell lines, human papillomavirus (HPV)-immortalized keratinocytes, and keratinocytes derived from a LSIL. Using in situ hybridization techniques to study the cervical tissue specimens, we found that MT1-MMP expression increases with cervical tumor progression (Spearman correlation coefficient = 0.66; P < 0.0001, exact test). Specifically, MT1-MMP expression is very low or absent in normal cervix and LSILs, is readily detectable in HSILs, and is very strongly expressed in nearly all invasive carcinomas. Most but not all cervical cancer-derived cell lines also expressed significant levels of MT1-MMP and MMP-2. Constitutive expression of exogenous MT1-MMP in cervical carcinoma-derived cells and HPV-immortalized keratinocytes with low endogenous levels of MT1-MMP induced invasiveness in collagen I, but this effect was not observed in LSIL-derived keratinocytes. Our results show that MT1-MMP is a key enzyme mediating cervical cancer progression. However, MT1-MMP alone is not always sufficient for inducing keratinocyte invasiveness at least in the collagen I invasion assay used in this study. Further studies of gene expression in preinvasive and invasive cervical cancers should assist with identification of additional critical factors mediating cervical cancer progression.
Assuntos
Carcinoma de Células Escamosas/enzimologia , Carcinoma de Células Escamosas/patologia , Metaloendopeptidases/biossíntese , Neoplasias do Colo do Útero/enzimologia , Neoplasias do Colo do Útero/patologia , Linhagem Celular Tumoral , Progressão da Doença , Feminino , Células HeLa , Humanos , Hibridização In Situ , Metaloproteinase 2 da Matriz/biossíntese , Metaloproteinases da Matriz Associadas à Membrana , Invasividade Neoplásica , Inibidor Tecidual de Metaloproteinase-2/biossíntese , Displasia do Colo do Útero/enzimologia , Displasia do Colo do Útero/patologiaRESUMO
Acute graft-versus-host disease (GVHD) and leukemic relapse are the two major obstacles to successful outcomes after allogeneic bone marrow transplantation (BMT), an effective therapy for hematological malignancies. Several studies have demonstrated that the dysregulation of proinflammatory cytokines and the loss of gastrointestinal tract integrity contribute to GVHD, whereas the donor cytotoxic responses are critical for graft-versus-leukemia (GVL) preservation. Suberoylanilide hydroxamic acid (SAHA) is currently in clinical trials as an antitumor agent; it inhibits the activity of histone deacetylases and at low doses exhibits antiinflammatory effects by reducing the production of proinflammatory cytokines. Using two well characterized mouse models of BMT, we have studied the effects of SAHA on GVHD severity and GVL activity. Administration of SAHA from day +3 to day +7 after BMT reduced serum levels of the proinflammatory cytokines and decreased intestinal histopathology, clinical severity, and mortality from acute GVHD compared with vehicle-treated animals. However, SAHA had no effect on donor T cell proliferative and cytotoxic responses to host antigens in vivo or in vitro. When mice received lethal doses of tumor cells at the time of BMT, administration of SAHA did not impair GVL activity and resulted in significantly improved leukemia-free survival by using two different tumor and donor/recipient combinations. These findings reveal a critical role for histone deacetylase inhibition in the proinflammatory events contributing to GVHD and suggest that this class of pharmacologic agents may provide a strategy to reduce GVHD while preserving cytotoxic T cell responses to host antigens and maintaining beneficial GVL effects.
Assuntos
Doença Enxerto-Hospedeiro/tratamento farmacológico , Inibidores de Histona Desacetilases , Ácidos Hidroxâmicos/farmacologia , Sistema Imunitário/efeitos dos fármacos , Animais , Transplante de Medula Óssea/imunologia , Citocinas/efeitos dos fármacos , Feminino , Sistema Imunitário/imunologia , Leucemia/imunologia , Camundongos , Transplante Homólogo , VorinostatRESUMO
Cancer cells are able to proliferate at accelerated rates within the confines of a three-dimensional (3D) extracellular matrix (ECM) that is rich in type I collagen. The mechanisms used by tumor cells to circumvent endogenous antigrowth signals have yet to be clearly defined. We find that the matrix metalloproteinase, MT1-MMP, confers tumor cells with a distinct 3D growth advantage in vitro and in vivo. The replicative advantage conferred by MT1-MMP requires pericellular proteolysis of the ECM, as proliferation is fully suppressed when tumor cells are suspended in 3D gels of protease-resistant collagen. In the absence of proteolysis, tumor cells embedded in physiologically relevant ECM matrices are trapped in a compact, spherical configuration and unable to undergo changes in cell shape or cytoskeletal reorganization required for 3D growth. These observations identify MT1-MMP as a tumor-derived growth factor that regulates proliferation by controlling cell geometry within the confines of the 3D ECM.
Assuntos
Divisão Celular/fisiologia , Matriz Extracelular/enzimologia , Metaloendopeptidases/metabolismo , Invasividade Neoplásica/fisiopatologia , Neoplasias/enzimologia , Animais , Tamanho Celular/fisiologia , Colágeno Tipo I/metabolismo , Colágeno Tipo I/ultraestrutura , Citoesqueleto/metabolismo , Citoesqueleto/ultraestrutura , Cães , Matriz Extracelular/ultraestrutura , Substâncias de Crescimento/metabolismo , Humanos , Metaloproteinases da Matriz Associadas à Membrana , Microscopia Eletrônica , Neoplasias/fisiopatologia , Proteínas Repressoras/metabolismo , Células Tumorais Cultivadas/metabolismo , Células Tumorais Cultivadas/ultraestruturaRESUMO
Cross-linked fibrin is deposited in tissues surrounding wounds, inflammatory sites, or tumors and serves not only as a supporting substratum for trafficking cells, but also as a structural barrier to invasion. While the plasminogen activator-plasminogen axis provides cells with a powerful fibrinolytic system, plasminogen-deleted animals use alternate proteolytic processes that allow fibrin invasion to proceed normally. Using fibroblasts recovered from wild-type or gene-deleted mice, invasion of three-dimensional fibrin gels proceeded in a matrix metalloproteinase (MMP)-dependent fashion. Consistent with earlier studies supporting a singular role for the membrane-anchored MMP, MT1-MMP, in fibrin-invasive events, fibroblasts from MT1-MMP-null mice displayed an early defect in invasion. However, MT1-MMP-deleted fibroblasts circumvented this early deficiency and exhibited compensatory fibrin-invasive activity. The MT1-MMP-independent process was sensitive to MMP inhibitors that target membrane-anchored MMPs, and further studies identified MT2-MMP and MT3-MMP, but not MT4-MMP, as alternate pro-invasive factors. Given the widespread distribution of MT1-, 2-, and 3-MMP in normal and neoplastic cells, these data identify a subset of membrane-anchored MMPs that operate in an autonomous fashion to drive fibrin-invasive activity.